Study Data – Electronic Records Useful in Predicting Patients with Low Back Pain, See DRX9000 or ISCS
BY ADMIN /
THURSDAY, 31 MARCH 2016 /
Study Data – Electronic Records Useful in Predicting
Patients with Low Back Pain, see DRX9000 or ISCS.
A study in Pain Research & Management suggests
that data from electronic health records (EHRs) could be used to develop a
predictive model for patients likely to develop low back pain (LBP). In many cases, the researchers acknowledge,
pain episodes and flare-ups naturally remit and recur in an episodic manner,
and patients can engage in self-care and activity avoidance during those
flare-ups to minimize the impact.
“However, for a substantial minority of patients, the pain episodes become
more frequent, more intense, or increase in duration, and eventually progress
to a more severe disease stage with consequences for treatment response, mental
health, physical functioning, and utilization of health care,” the study
authors note.
But are there enough pain signals within routinely
collected clinical data within EHRs to predict future utilization
patterns? The researchers used a
database maintained by Geisinger Health System to develop a series of logistic
regression models to predict who will be a high-cost patient (defined as top
30% of the cost distribution) at each of the first 3 LBP visits. High cost was
defined as any patient who used care over the subsequent 12 months that was
greater than $1,176, the 70th percentile of the distribution. They found that,
with a high degree of variability, they were able to fairly accurately predict
with patients would become high utilizers of healthcare services.
Some of the more interesting study findings:
· Men are
more likely to become expensive than women
· Patients
receiving workers’ compensation as their primary payer type, had higher use of
prescription opioids, or were smokers before their first LBP visit were more
likely to become expensive.
· Patients
whose first encounter was with a primary care physician were less likely to
become expensive than those who received their first LBP care elsewhere.
Some of the limitations of the study include that it
only measured those who had at least one year of follow-up after the first LBP
visit. “This may have biased the sample selection process because patients who
did not meet this criterion may have had systematically less severe LBP,” the
researchers note. Second, not all of the data used by the researchers is
available in all EHRs—including the financial variables. Still, they argue that their model allows
the potential to identify potentially expensive patients in real time before
they become truly expensive.
That is a tantalizing notion for managed care
organizations, certainly, but also has potentially substantial positive benefit
for future pain patients. “As the era of electronic medical records move beyond
its current infancy, however, EHR-based predictive modelling strategies, such as
the one presented herein, are likely to become more feasible and commonplace,”
the researchers conclude.
Integrity Life Sciences delivers a multitude of
orthotic treatment options to address one of the most costly systemic ailments
in the world, chronic low back and neck pain. Our advanced solution begins with
the Integrity Spinal Care System (ISCS) ™ and its proprietary iELCiPS
Technology™. The ISCS non-surgical spinal decompression modality systems are
engineered to provide pain relief for compressive and degenerative conditions
of the spine. Specifically, conditions that may be treated include: neck pain
and back pain associated with herniated discs, protruding discs, degenerative
disc disease, posterior facet syndrome, and sciatica. It achieves these effects
through decompression of intervertebral discs, that is, unloading due to
distraction and positioning.
As a compliment to the ISCS, Integrity offers the very
effective Integrity Gel Support Brace™. Our advanced lumbar support brace is a
fitting compliment to non-surgical spinal decompression therapy and was
designed as an adjunct therapy for those suffering from back pain due to disc
related conditions. The Integrity Gel Support Brace may be used with or without
Integrity’s non-surgical spinal decompression systems and is an excellent
treatment option for the patient to use at home. Integrity Life Sciences
delivers a multitude of orthotic treatment options to address one of the most
costly systemic ailments in the world, chronic low back and neck pain. Our
advanced solution begins with the Integrity Spinal Care System (ISCS) ™ and its
proprietary iELCiPS Technology™. The ISCS non-surgical spinal decompression
modality systems are engineered to provide pain relief for compressive and
degenerative conditions of the spine. Specifically, conditions that may be
treated include: neck pain and back pain associated with herniated discs,
protruding discs, degenerative disc disease, posterior facet syndrome, and
sciatica. It achieves these effects through decompression of intervertebral
discs, that is, unloading due to distraction and positioning.
As a compliment to the ISCS, Integrity offers the very
effective Integrity Gel Support Brace™. Our advanced lumbar support brace is a
fitting compliment to non-surgical spinal decompression therapy and was
designed as an adjunct therapy for those suffering from back pain due to disc
related conditions. The Integrity Gel Support Brace may be used with or without
Integrity’s non-surgical spinal decompression systems and is an excellent
treatment option for the patient to use at home.
In addition, Integrity Life Sciences has been
exclusively granted the use of all of the technology, products, US Patent and
Trademark Office’s assignments, logos and other forms of intellectual property
that were created by Axiom Worldwide, INC under the leadership of Jim Gibson
from Tampa, Florida. The agreement specifically includes the flagship product
DRX 9000™, its family of products, and all of its derivatives such as the
DRX9000C. Integrity offers support for these products, which includes: sales,
maintenance services, and repairs. Only Integrity Life Sciences is Registered
with the US FDA as a Factory Authorized – Contract Manufacturer – for Axiom
Worldwide and the DRX9000 True Non-Surgical Spinal Decompression Systems™
James Gibson, President of Integrity Life Sciences and
Axiom Worldwide states “Our partners, in over 50 countries and territories,
have the unique opportunity to present a cutting edge medical device, utilizing
a clinically validated protocol that restores a patient’s quality of life
non-surgically and without pharmaceutical or invasive intervention“. With a
body of published clinical research from around the world will support and
strengthen your sales presentation; members of our medical advisory board
herald from prestigious institutions such as Johns-Hopkins and The Mayo Clinic
just to name a few. In addition, partners will have confidence in a quality
product that adheres to the stringent standards mandated by FDA, CE, and ISO.
Sales, marketing, and technical training is offered in prestigious locations in
Europe, Asia, the Middle East and throughout the United States.
Learn more @: www.IntegrityLifeSciences.com or
www.AxiomWorldwide.com
Integrity Life Sciences, LLC and Axiom Worldwide, INC
are privately held companies with global interests and shareholders with
international partners located across the globe with a mission of “Restoring
Integrity to the Spine™” and delivering "True Non-Surgical Spinal
Decompression"
For additional information please visit:
www.IntegrityLifeSciences.com.
Elements as Published in: MD Magazine
No comments:
Post a Comment